These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3510855)

  • 1. Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats.
    Terrettaz J; Assimacopoulos-Jeannet F; Jeanrenaud B
    Endocrinology; 1986 Feb; 118(2):674-8. PubMed ID: 3510855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats.
    Terrettaz J; Jeanrenaud B
    Endocrinology; 1983 Apr; 112(4):1346-51. PubMed ID: 6339203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
    Kolterman OG; Insel J; Saekow M; Olefsky JM
    J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of epinephrine-stimulated gluconeogenesis by insulin in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutierrez JC; Sánchez-Arias JA; Samper B; Felíu JE
    Endocrinology; 1997 Jun; 138(6):2443-8. PubMed ID: 9165034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vanadate decreases muscle insulin resistance in obese fa/fa rats.
    Brichard SM; Ongemba LN; Henquin JC
    Diabetologia; 1992 Jun; 35(6):522-7. PubMed ID: 1612224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased responsiveness of basal gluconeogenesis to insulin action in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutiérrez JC; Sánchez-Arias JA; Lechuga CG; Valle JC; Samper B; Felíu JE
    Endocrinology; 1994 Apr; 134(4):1868-73. PubMed ID: 8137754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo insulin resistance during nonlethal hypermetabolic sepsis.
    Lang CH; Dobrescu C
    Circ Shock; 1989 Jun; 28(2):165-78. PubMed ID: 2661048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the new oral antidiabetic agent (-)-BM 13.0913.Na on insulin resistance in lean and obese Zucker rats.
    Apweiler R; Kühnle HF; Ritter G; Schell R; Freund P
    Metabolism; 1995 May; 44(5):577-83. PubMed ID: 7752904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.
    Leonard BL; Watson RN; Loomes KM; Phillips AR; Cooper GJ
    Acta Diabetol; 2005 Dec; 42(4):162-70. PubMed ID: 16382303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin action during fasting and refeeding in rat determined by euglycemic clamp.
    Pénicaud L; Kandé J; Le Magnen J; Girard JR
    Am J Physiol; 1985 Nov; 249(5 Pt 1):E514-8. PubMed ID: 3904481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gluconeogenesis by epinephrine in hepatocytes isolated from genetically obese (fa/fa) Zucker rats.
    Sánchez-Gutiérrez JC; Sánchez-Arias JA; Samper B; Felíu JE
    Arch Biochem Biophys; 2000 Jan; 373(1):249-54. PubMed ID: 10620345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glyburide increases insulin sensitivity and responsiveness in peripheral tissues of the rat as determined by the glucose clamp technique.
    Hirshman MF; Horton ES
    Endocrinology; 1990 May; 126(5):2407-12. PubMed ID: 2109686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of insulin sensitivity in obese offspring of diabetic rats by hyperinsulinemic-euglycemic clamp technique.
    Gelardi NL; Cha CJ; Oh W
    Pediatr Res; 1991 Jul; 30(1):40-4. PubMed ID: 1891280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo metabolic changes as studied longitudinally after ventromedial hypothalamic lesions.
    Pénicaud L; Rohner-Jeanrenaud F; Jeanrenaud B
    Am J Physiol; 1986 Jun; 250(6 Pt 1):E662-8. PubMed ID: 3521313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia and its impact on obesity and insulin resistance.
    Cusin I; Rohner-Jeanrenaud F; Terrettaz J; Jeanrenaud B
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S1-11. PubMed ID: 1338381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of obesity on insulin sensitivity and responsiveness in sheep.
    Bergman EN; Reulein SS; Corlett RE
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E772-81. PubMed ID: 2688439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production.
    den Boer MA; Voshol PJ; Kuipers F; Romijn JA; Havekes LM
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1360-4. PubMed ID: 16849628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.